Merck KGaA (MRK) PT Set at €100.00 by J P Morgan Chase & Co

Merck KGaA (FRA:MRK) has been given a €100.00 ($117.65) price target by analysts at J P Morgan Chase & Co in a report issued on Wednesday. The brokerage currently has a “neutral” rating on the healthcare company’s stock. J P Morgan Chase & Co’s price objective would suggest a potential upside of 7.82% from the stock’s current price.

MRK has been the subject of a number of other reports. HSBC Holdings plc set a €94.00 ($110.59) price objective on Merck KGaA and gave the stock a “neutral” rating in a research report on Wednesday, August 9th. Independent Research GmbH set a €105.00 ($123.53) price objective on Merck KGaA and gave the stock a “neutral” rating in a research report on Wednesday, September 6th. Kepler Capital Markets set a €115.00 ($135.29) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Wednesday, October 4th. Berenberg Bank set a €116.00 ($136.47) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Tuesday, September 19th. Finally, Citigroup Inc. set a €123.00 ($144.71) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Monday, September 25th. Thirteen research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of €109.17 ($128.44).

COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/11/03/merck-kgaa-mrk-pt-set-at-100-00-by-j-p-morgan-chase-co.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

What are top analysts saying about Merck KGaA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merck KGaA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit